Stratigos, A.J., Sekulic, A., Peris, K., Bechter, O., Prey, S., Kaatz, M., Lewis, K.D., Basset-Seguin, N., Chang, A.L.S., Dalle, S., Orland, A.F., Licitra, L., Robert, C., Ulrich, C., Hauschild, A., Migden, M.R., Dummer, R., Yoo, S.-Y., Coates, E., Okoye, E., Bassukas, I., Loquai, C., De Giorgi, V., Eroglu, Z., Gutzmer, R., Ulrich, J., Puig, S., Seebach, F., Lowy, I. and Fury, M.G. 2023. Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s178. DOI:https://doi.org/10.25251/skin.7.supp.178.